Medika Natura is a clinical-stage company focusing on botanical drugs and high-value herbal ingredients of Malaysian and Southeast Asian origin Medika Natura’s patent-pending core product, SKF7® (Standardized extract Kacip Fatimah), is Malaysia’s first-ever herbal ingredient to receive U.S. Food and Drug Administration (USFDA) clearance as a New Dietary Ingredient (NDI) in 2020. It is also pending clearance from the European Food Safety Authority (EFSA) as a Novel Food, which is expected to receive in 2022. Medika Natura is scaling up activities in Herbal Plantation, Herbal Extractions, Manufacturing and moving into the Asia, United States, EU with a diversified ingredient and product pipeline. We are committed to scientific research and testing to global standards and continuously seeking to develop innovations that make things that matter, better.